10月20日 - ** 全球最大制药商礼来公司（Eli Lilly， LLY.N）股价上涨5.45%，创下1,307.91美元的历史新高
** 该股此前52周最高价为1,292.65美元
** 据伦敦证券交易所集团（LSEG）数据显示，华尔街对这只市值达万亿美元的股票普遍持乐观态度，29位分析师给予“买入”或“强烈买入”评级，3位给予“持有”评级，1位给予“卖出”评级，目标价中位数为1,380.50美元
** LLY通过一系列收购和授权协议扩大了其药物研发管线，利用其糖尿病和减肥药物带来的强劲现金流，推动更广泛的并购活动
** 其他大型制药商，包括安进（Amgen） AMGN.O、辉瑞（Pfizer） PFE.N、强生（Johnson & Johnson） JNJ.N 和艾伯维（AbbVie） ABBV.N，在早盘交易中也均有所上涨；更广泛的标普500医疗保健指数 .SPXHC 触及历史新高
** 算上本交易日的涨幅，LLY股票今年以来累计上涨约21%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.